TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial.

Palmer, Daniel H; Valle, Juan W; Ma, Yuk Ting; Faluyi, Olusola; Neoptolemos, John P; Jensen Gjertsen, Trine; Iversen, Berit; Amund Eriksen, Jon; Møller, Anne-Sophie; Aksnes, Anne-Kirsti; Miller, Robert; Dueland, Svein

Palmer, Daniel H; Valle, Juan W; Ma, Yuk Ting; Faluyi, Olusola; Neoptolemos, John P; Jensen Gjertsen, Trine; Iversen, Berit; Amund Eriksen, Jon; Møller, Anne-Sophie; Aksnes, Anne-Kirsti; Miller, Robert; Dueland, Svein.

Affiliation

Palmer DH; Liverpool Experimental Cancer Medicine Centre, Liverpool, UK. palmerd@liverpool.ac.uk.
Valle JW; The Clatterbridge Cancer Centre, Bebington, Wirral, UK. palmerd@liverpool.ac.uk.
Ma YT; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Faluyi O; The Christie NHS Foundation Trust, Manchester, UK.
Neoptolemos JP; Queen Elizabeth Hospital, Birmingham, UK.
Jensen Gjertsen T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Iversen B; The Clatterbridge Cancer Centre, Bebington, Wirral, UK.
Amund Eriksen J; Liverpool Experimental Cancer Medicine Centre, Liverpool, UK.
Møller AS; Targovax ASA, Oslo, Norway.
Aksnes AK; Targovax ASA, Oslo, Norway.
Miller R; Targovax ASA, Oslo, Norway.
Dueland S; Targovax ASA, Oslo, Norway.

Br J Cancer ; 122(7): 971-977, 2020 03.

Article in En | MEDLINE | ID: mdl-32063605

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Granulocyte-Macrophage Colony-Stimulating Factor / Deoxycytidine Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2020 Document type: Article Affiliation country: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google